Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron versus haloperidol for prevention of postoperative nausea and vomiting
IRCT20210926052586N1Phase 4Completed
- Sponsor
- Islamic Azad University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Ondansetron with Haloperidol (2 arms). Primary endpoint: Comparison of the effect of ondansetron and haloperidol on postoperative nausea in patients. Started Oct 2021; status: completed.
02
Drugs
ondansetronhaloperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20210926052586N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210926052586N1.